HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Enrico Calzia Selected Research

Cystathionine

1/2022The H2S Donor Sodium Thiosulfate (Na2S2O3) Does Not Improve Inflammation and Organ Damage After Hemorrhagic Shock in Cardiovascular Healthy Swine.
1/2022Effects of Sodium Thiosulfate During Resuscitation From Trauma-and-Hemorrhage in Cystathionine-γ-Lyase Knockout Mice With Diabetes Type 1.
1/2022Effects of Sodium Thiosulfate During Resuscitation From Trauma-and-Hemorrhage in Cystathionine Gamma Lyase (CSE) Knockout Mice.
1/2020Effects of sodium thiosulfate (Na2S2O3) during resuscitation from hemorrhagic shock in swine with preexisting atherosclerosis.
10/2018Cystathionine-γ-lyase expression is associated with mitochondrial respiration during sepsis-induced acute kidney injury in swine with atherosclerosis.
12/2017Impact of hyperglycemia on cystathionine-γ-lyase expression during resuscitated murine septic shock.
1/2017The Role of Cystathionine-γ-Lyase In Blunt Chest Trauma in Cigarette Smoke Exposed Mice.
5/2016Effects of Hyperoxia and Mild Therapeutic Hypothermia During Resuscitation From Porcine Hemorrhagic Shock.
4/2014Regulation of mitochondrial bioenergetic function by hydrogen sulfide. Part II. Pathophysiological and therapeutic aspects.
12/2011Cardiopulmonary, histologic, and inflammatory effects of intravenous Na2S after blunt chest trauma-induced lung contusion in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Enrico Calzia Research Topics

Disease

26Shock
01/2023 - 01/2007
16Inflammation (Inflammations)
01/2022 - 01/2009
16Sepsis (Septicemia)
01/2022 - 10/2006
15Hemorrhage
01/2023 - 07/2012
14Hemorrhagic Shock
01/2023 - 07/2012
13Wounds and Injuries (Trauma)
01/2022 - 12/2011
12Hyperoxia
01/2023 - 11/2006
12Septic Shock (Toxic Shock Syndrome)
01/2022 - 02/2008
8Hypoxia (Hypoxemia)
01/2023 - 10/2008
8Peritonitis
10/2018 - 01/2007
8Hypothermia
11/2017 - 10/2008
7Acidosis
01/2022 - 02/2008
7Atherosclerosis
01/2022 - 03/2013
6Coronary Artery Disease (Coronary Atherosclerosis)
01/2022 - 01/2017
6Reperfusion Injury
01/2020 - 07/2008
5Critical Illness (Critically Ill)
01/2022 - 12/2006
5Hypotension (Low Blood Pressure)
01/2022 - 09/2007
4Brain Injuries (Brain Injury)
01/2023 - 12/2019
4Lactic Acidosis
01/2022 - 07/2013
4Hyperglycemia
01/2022 - 06/2014
4Mitochondrial Diseases (Mitochondrial Disease)
01/2021 - 09/2007
4Acute Lung Injury
01/2020 - 11/2008
4Ischemia
03/2013 - 07/2008
3Acute Kidney Injury (Acute Renal Failure)
10/2018 - 03/2013
2Acute Subdural Hematoma
01/2023 - 01/2021
2Traumatic Brain Injuries (Traumatic Brain Injury)
01/2023 - 02/2010
2Chronic Obstructive Pulmonary Disease (COPD)
01/2022 - 01/2017
2Alzheimer Disease (Alzheimer's Disease)
01/2021 - 10/2017
2Hypercholesterolemia
10/2018 - 12/2013
2Lung Injury
01/2017 - 12/2011
2B-Cell Lymphoma (Lymphoma, B Cell)
01/2017 - 05/2016
2Bradycardia
12/2011 - 02/2010
2Multiple Organ Failure (MODS)
09/2011 - 01/2007
2Hyperlactatemia
01/2009 - 10/2008
1Heart Failure
12/2023

Drug/Important Bio-Agent (IBA)

15Oxygen (Dioxygen)IBA
01/2023 - 10/2006
14CytokinesIBA
01/2023 - 01/2009
13Norepinephrine (Noradrenaline)FDA LinkGeneric
01/2022 - 10/2008
12Hydrogen Sulfide (Sulfide, Hydrogen)IBA
01/2022 - 10/2008
10CystathionineIBA
01/2022 - 12/2011
9LyasesIBA
01/2022 - 12/2011
93-nitrotyrosineIBA
12/2019 - 12/2013
9Glucose (Dextrose)FDA LinkGeneric
10/2018 - 09/2007
8Proteins (Proteins, Gene)FDA Link
01/2021 - 09/2011
8salicylhydroxamic acid (SHAM)IBA
01/2019 - 04/2011
8CreatinineIBA
10/2018 - 01/2009
6sodium thiosulfateFDA Link
01/2023 - 01/2020
6Nitric Oxide (Nitrogen Monoxide)FDA Link
12/2016 - 01/2008
5SmokeIBA
01/2022 - 01/2015
5CatecholaminesIBA
01/2022 - 12/2006
5GasesIBA
01/2020 - 05/2016
5Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
10/2019 - 12/2013
5Sulfides (Thioethers)IBA
01/2019 - 10/2008
5ErythropoietinFDA Link
03/2013 - 01/2008
5Interleukin-6 (Interleukin 6)IBA
03/2013 - 01/2009
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2013 - 01/2009
4Heme Oxygenase-1IBA
01/2017 - 04/2011
4AcidsIBA
01/2017 - 01/2008
4NitratesIBA
03/2013 - 02/2008
4Arginine Vasopressin (Argipressin)IBA
01/2009 - 01/2007
3IsotopesIBA
01/2023 - 01/2009
3Reactive Oxygen Species (Oxygen Radicals)IBA
01/2023 - 02/2008
3Biomarkers (Surrogate Marker)IBA
01/2022 - 11/2012
3EnzymesIBA
01/2022 - 04/2014
3Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 10/2010
3Amyloid (Amyloid Fibrils)IBA
01/2021 - 01/2016
3AlbuminsIBA
12/2019 - 05/2016
3ChemokinesIBA
01/2017 - 04/2011
3Caspase 3 (Caspase-3)IBA
05/2016 - 12/2011
3NitritesIBA
03/2013 - 01/2009
3Vasopressins (Vasopressin)IBA
01/2008 - 12/2006
2Hormones (Hormone)IBA
01/2023 - 11/2020
23-mercaptopyruvate sulphurtransferaseIBA
02/2021 - 01/2019
2NAD (NADH)IBA
01/2021 - 01/2016
2Amyloid beta-PeptidesIBA
01/2021 - 01/2016
2Vasoconstrictor AgentsIBA
10/2019 - 12/2013
2Troponin IIBA
10/2019 - 01/2009
2Purinergic Receptors (Receptors, Purine)IBA
01/2017 - 02/2015
2Blood Glucose (Blood Sugar)IBA
01/2017 - 01/2009
2CarbohydratesIBA
01/2017 - 07/2013
2AntioxidantsIBA
06/2014 - 08/2009
2carbamylated erythropoietinIBA
03/2013 - 09/2011
2Indicators and Reagents (Reagents)IBA
11/2012 - 11/2008
2sodium sulfideIBA
07/2012 - 12/2011
2Starch (Cornstarch)IBA
07/2012 - 08/2009
2Hemoglobins (Hemoglobin)IBA
10/2010 - 02/2008
2IsoprostanesIBA
08/2009 - 02/2008
2DNA (Deoxyribonucleic Acid)IBA
08/2009 - 02/2008
1Adrenergic Receptors (Adrenergic Receptor)IBA
12/2023
1Superoxides (Superoxide)IBA
01/2023

Therapy/Procedure

22Resuscitation
01/2023 - 11/2006
12Critical Care (Surgical Intensive Care)
01/2023 - 01/2007
12Artificial Respiration (Mechanical Ventilation)
06/2021 - 02/2010
4Anesthesia
01/2022 - 02/2010
4Ligation
01/2019 - 12/2013
4Therapeutics
01/2019 - 01/2008
4Punctures
01/2019 - 12/2013
3Positive-Pressure Respiration (Positive End-Expiratory Pressure)
01/2020 - 10/2004
3Induced Hypothermia
11/2017 - 07/2013
2Catheters
01/2017 - 12/2016